cancer - International Biopharmaceutical Industry

news

AstraZeneca and Daiichi set to broaden use of breast cancer drug, challenging Roche

Dive Brief: The Food and Drug Administration approved the antibody treatment Enhertu for earlier use in breast cancer patients, the latest milestone for a drug tha...

9 May 2022 news AstraZeneca | breast

Continue Reading →

news

Novartis suspends production of two radiopharmaceutical drugs over quality concerns

Dive Brief: Novartis has suspended production of two cancer drugs at plants in Italy and New Jersey due to “potential quality issues” it identified in its manufact...

9 May 2022 news cancer | Drugs

Continue Reading →

news

Cancer Research UK reveals innovation engine underpinned by £400m portfolio of cutting-edge discovery science

Cancer Research UK, the world's largest independent funder of cancer research, today (Tuesday 26th), unveiled Cancer Research Horizons, its new and ambitious approach...

28 April 2022 news cancer | Horizons

Continue Reading →

news

A promising cancer drug leads Regeneron to reconsider its aversion to M&A

Dive Brief: Regeneron has agreed to purchase a young biotechnology company for access to a drug that the buyer believes will be a valuable component in cancer-figh...

25 April 2022 news biotechnology | cancer

Continue Reading →

news

Seagen to expand, add jobs with new cancer drug factory

Dive Brief: Seagen, the largest biotechnology company in the Seattle area, has unveiled plans for a manufacturing facility to help provide "greater control and fle...

25 April 2022 news cancer | Drug

Continue Reading →

news

FDA panel supports agency push to raise approval bar for certain cancer drugs

The Food and Drug Administration appears ready to raise its approval standards for a well-known class of cancer drugs due to concerns they aren't helping patients liv...

25 April 2022 news blood | cancer

Continue Reading →

news

GSK acquires Sierra Oncology, betting $2B on a bone cancer drug with a long history

GlaxoSmithKline has agreed to acquire Sierra Oncology for $1.9 billion in a bet that an experimental drug the small biotech developed is on the cusp of becoming a val...

14 April 2022 news cancer | Drug

Continue Reading →

news

AACR 2022: NK cell promise, more TIGIT questions and extending CAR-T’s reach

Each year, the American Association for Cancer Research’s conference spotlights promising early research into new approaches for attacking tumors. This year's meeting...

14 April 2022 news cancer | CAR-T

Continue Reading →

news

FDA clears Gilead to restart some studies of top cancer drug

Dive Brief: The Food and Drug Administration has cleared Gilead to restart some trials testing an experimental cancer drug the company acquired in a roughly $5 bil...

14 April 2022 news cancer | Drug

Continue Reading →

news

Novartis breast cancer drug approved for ultra-rare condition

Dive Brief: The Food and Drug Administration has approved the first drug to treat an ultra-rare cluster of conditions caused by mutations in a specific gene, grant...

11 April 2022 news breast | cancer

Continue Reading →